How would you like to read? Click one below.
At any time, click this 
to change word size.
Disclaimer
By selecting this link, you will be leaving www.LUCENTIS.com and going to a site that is not controlled by or affiliated with Genentech USA, Inc. Genentech is neither affiliated with nor endorses any of the aforementioned organizations. The information provided by Genentech or these organizations is meant for informational purposes only and is not meant to replace your doctor's medical advice.
Disclaimer
The information contained in this section of the site is intended for U.S. healthcare professionals only. Click "OK" if you are a healthcare professional.
Who is LUCENTIS for?
LUCENTIS® (ranibizumab injection) is a prescription medicine for the treatment of patients with wet age-related macular degeneration (wAMD).
What important safety information should I know about LUCENTIS?
LUCENTIS is a prescription medication given by injection into the eye, and it has side effects. Some LUCENTIS patients have had detached retinas and serious infections inside the eye. You should not use LUCENTIS if you have an infection in or around the eye or are allergic to LUCENTIS or any of its ingredients.
Uncommonly, LUCENTIS patients have had serious, sometimes fatal, problems related to blood clots, such as heart attacks or strokes.
Some patients have had increased eye pressure before and within 1 hour of an injection.
Serious side effects include inflammation inside the eye and, rarely, problems related to the injection procedure, such as cataracts. These side effects can make your vision worse.
The most common eye-related side effects are increased redness in the white of the eye, eye pain, small specks in vision, and increased eye pressure. The most common non–eye-related side effects are nose and throat infections, headache, joint pain, and lung/airway infections.
If your eye becomes red, sensitive to light, or painful, or if you have a change in vision, call or visit your eye doctor right away.
For additional safety information, please talk to your doctor and see the LUCENTIS full prescribing information.
MACULAR DEGENERATION
Ed K.'s Story
Ed K.'s wife, Barbara, is living with wet AMD
It was sometime in 2005 when we first heard the term wet AMD applied to my wife's vision loss. Around the same time, we learned she required an operation for breast cancer. As they were taking her to surgery, she began to cry. We'd been through serious medical problems before, but I'd never seen her cry.
“I asked her what was wrong, and she said, 'I can't see your face.'”
I walked back to the hospital bed and kissed her again. Ironically, I began to worry more about her eyes than her impending surgery. This incident, more than any other, forced me to face the very real possibility that my wife could become blind, and it wasn't something I was ready to deal with—not then, not ever. Fortunately, my wife's surgery was successful, but her vision wasn't improving.
In the summer of 2006, we learned about LUCENTIS, and after doing some research, my wife received her first treatment in July. It took some time, but after several injections—8 injections in her left eye, and 4 in her right—my wife noticed improvement. My wife's left eye has improved. What I noticed was the fact that she saw faces on the TV again. She began to talk about the smile of a grandchild, the leaves on a tree, the beauty of snow clinging to the bushes, and she could even say with certainty if a traffic light was red or green. And all of these things meant the world to me.
I know her eyesight will never be perfect, yet my wife can live her life with wet AMD thanks to her successful treatment and partnership with her Retina Specialist.
Please see important safety information below.
Who is LUCENTIS for?
LUCENTIS® (ranibizumab injection) is a prescription medicine for the treatment of patients with wet age-related macular degeneration (wAMD).
What important safety information should I know about LUCENTIS?
LUCENTIS is a prescription medication given by injection into the eye, and it has side effects. Some LUCENTIS patients have had detached retinas and serious infections inside the eye. You should not use LUCENTIS if you have an infection in or around the eye or are allergic to LUCENTIS or any of its ingredients.
Uncommonly, LUCENTIS patients have had serious, sometimes fatal, problems related to blood clots, such as heart attacks or strokes.
Some patients have had increased eye pressure before and within 1 hour of an injection.
Serious side effects include inflammation inside the eye and, rarely, problems related to the injection procedure, such as cataracts. These side effects can make your vision worse.
The most common eye-related side effects are increased redness in the white of the eye, eye pain, small specks in vision, and increased eye pressure. The most common non–eye-related side effects are nose and throat infections, headache, joint pain, and lung/airway infections.
If your eye becomes red, sensitive to light, or painful, or if you have a change in vision, call or visit your eye doctor right away.
For additional safety information, please talk to your doctor and see the LUCENTIS full prescribing information.
This site is intended for US residents only.
